Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 7, 2018
Total Value: $986M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHEMOCENTRYX INC | 7,201,316 | $97.94M | 9.9% | — | — | COM | 16383L106 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 5,542,400 | $85.52M | 8.7% | — | — | COM CL A | 46333X108 |
| — | ARRAY BIOPHARMA INC | 5,062,768 | $82.62M | 8.4% | — | — | COM | 04269X105 |
| — | BLUEPRINT MEDICINES CORP | 655,611 | $60.12M | 6.1% | — | — | COM | 09627Y109 |
| — | ARQULE INC | 16,436,912 | $47.34M | 4.8% | — | — | COM | 04269E107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,233,618 | $46.01M | 4.7% | — | — | COM | 87164F105 |
| — | MERUS N V | 2,419,443 | $44.83M | 4.5% | — | — | COM | N5749R100 |
| — | CONCERT PHARMACEUTICALS INC | 1,932,123 | $44.25M | 4.5% | — | — | COM | 206022105 |
| CYTK | CYTOKINETICS INC | 5,721,888 | $41.2M | 4.2% | — | — | COM NEW | 23282W605 |
| ANAB | ANAPTYSBIO INC | 386,065 | $40.18M | 4.1% | — | — | COM | 032724106 |
| XOMA | XOMA CORP DEL | 1,502,800 | $30.4M | 3.1% | — | — | COM NEW | 98419J206 |
| XNCR | XENCOR INC | 902,000 | $27.04M | 2.7% | — | — | COM | 98401F105 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $27.03M | 2.7% | — | — | COM NEW | 12648L601 |
| KURA | KURA ONCOLOGY INC | 1,353,846 | $25.39M | 2.6% | — | — | COM | 50127T109 |
| — | PIERIS PHARMACEUTICALS INC | 3,592,549 | $24.5M | 2.5% | — | — | COM | 720795103 |
| — | BIOLINERX LTD | 25,995,575 | $22.62M | 2.3% | — | — | SPONSORED ADR | 09071M106 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,954,254 | $22.53M | 2.3% | — | — | COM | 221015100 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 9,766,508 | $20.51M | 2.1% | — | — | COM | 45665G303 |
| RCUS | ARCUS BIOSCIENCES INC | 1,269,788 | $19.61M | 2.0% | — | — | COM | 03969F109 |
| SPRO | SPERO THERAPEUTICS INC | 1,048,958 | $14.95M | 1.5% | — | — | COM | 84833T103 |
| — | IMMUNE DESIGN CORP | 4,106,200 | $13.55M | 1.4% | — | — | COM | 45252L103 |
| — | ONCOMED PHARMACEUTICALS INC | 4,253,189 | $13.53M | 1.4% | — | — | COM | 68234X102 |
| — | ERYTECH PHARMA | 625,000 | $13.13M | 1.3% | — | — | SPONSORED ADR | 29604W108 |
| — | SPRING BK PHARMACEUTICALS INC | 832,247 | $12.8M | 1.3% | — | — | COM | 849431101 |
| — | VBI VACCINES INC | 3,100,000 | $10.85M | 1.1% | — | — | COM NEW | 91822J103 |
| — | GTX INC DEL | 609,748 | $10.82M | 1.1% | — | — | COM NEW | 40052B207 |
| — | FORWARD PHARMA A/S | 4,755,117 | $10.32M | 1.0% | — | — | SPONSORED ADR | 34986J105 |
| — | REGULUS THERAPEUTICS INC | 13,974,249 | $10.03M | 1.0% | — | — | COM | 75915K101 |
| — | VERASTEM INC | 2,737,000 | $8.156M | 0.8% | — | — | COM | 92337C104 |
| — | ADURO BIOTECH INC | 806,534 | $7.501M | 0.8% | — | — | COM | 00739L101 |
| — | ALBIREO PHARMA INC | 225,000 | $7.328M | 0.7% | — | — | COM | 01345P106 |
| — | TOCAGEN INC | 504,483 | $5.978M | 0.6% | — | — | COM | 888846102 |
| — | CONTRAFECT CORP | 3,500,000 | $5.565M | 0.6% | — | — | COM | 212326102 |
| — | MOLECULAR TEMPLATES INC | 688,629 | $5.509M | 0.6% | — | — | COM | 608550109 |
| — | ALPINE IMMUNE SCIENCES INC | 675,759 | $5.406M | 0.5% | — | — | COM | 02083G100 |
| — | GENOCEA BIOSCIENCES INC | 5,000,000 | $5.25M | 0.5% | — | — | COM | 372427104 |
| — | SUNESIS PHARMACEUTICALS INC | 1,684,636 | $4.582M | 0.5% | — | — | COM PAR | 867328700 |
| XENE | XENON PHARMACEUTICALS INC | 720,830 | $3.532M | 0.4% | — | — | COM | 98420N105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 405,600 | $3.484M | 0.4% | — | — | COM | 74366E102 |
| — | VICAL INC | 1,409,444 | $2.044M | 0.2% | — | — | COM NEW | 925602203 |
| — | ESSA PHARMA INC | 10,183,646 | $1.935M | 0.2% | — | — | COM | 29668H104 |
| — | LOXO ONCOLOGY INC | 4,386 | $506K | 0.1% | — | — | COM | 548862101 |
| — | OREXIGEN THERAPEUTICS INC | 534,900 | $108K | 0.0% | — | — | COM NEW | 686164302 |